-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IIyoFUp3LpKkMoYcd2JRh8g3VCNcJ5TvSCzO8Jfp0f7uHwGLak8GmFEI2NlBYFXc bNIKIW1b1gV/OofAdBA64g== 0000000000-08-004713.txt : 20080228 0000000000-08-004713.hdr.sgml : 20080228 20080128143620 ACCESSION NUMBER: 0000000000-08-004713 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080128 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: SALIX PHARMACEUTICALS LTD CENTRAL INDEX KEY: 0001009356 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943267443 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 1700 PERIMETER PARK DRIVE CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: (919) 862-1000 MAIL ADDRESS: STREET 1: 1700 PERIMETER PARK DRIVE CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SALIX HOLDINGS LTD DATE OF NAME CHANGE: 19970807 PUBLIC REFERENCE ACCESSION NUMBER: 0001193125-07-055440 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C4U(#`@;V)J(#P\+TQI;F5AF4@-C8O4')E=B`Y-C4U+UA29693=&T@-C@T+U)O;W0@-38@,"!2+TEN M9F\@-B`P(%(O241;/#4V,#A&0T0P,C,X,T)%-48U,C8T13,R044X-C8W-C)" M/CPS-C$W,S=".3(Q0S,P,#1#.#-&1$)&0D$P.34X1#A"-3Y=/CX-"G-T87)T M>')E9@T*,`T*)25%3T8-"B`@(`T*-C4@,"!O8FH\/"],96YG=&@@-SDO0R`X M.2]&:6QT97(O1FQA=&5$96-O9&4O22`Q,3$O3"`W,R]3(#,X/CYS=')E86T- M"GC:8F!@8&=@8-[,``1<5QE0`1,0LS!P-#`CB;%#,0.##P.W8.L^;M&'/MIP MY4)\4&T60,S(P,#7`:&9V^`&L#$P*#^$B#+J`008`.\Y"!8-"F5N9'-TF4@-34O5'EP92]84F5F/CYS=')E86T- M"GC:8F)B9&!B8&`'1=+T5X=$=3=&%T93P\+T=3,"`V,R`P M(%(^/CX^+U1Y<&4O4&%G93X^#65N9&]B:@TU."`P(&]B:CP\+U-U8G1Y<&4O M5')U951Y<&4O1F]N=$1E":6]840 M.SO[$#MIFVZV;LUNI^/I`\7RFM8Q&<#)>G]])01QB!%F-@\1V.*>HWOON1Q/ M%_#^_?1^]LL<,'SX<#V?P0C#UQ&!%$;3GY;ZNAA=1Z-I%&$@$&WTMU&B]T;/ M^A]$!1!LUN_FHQP(U2LV2X@AP!(%%**'D0?CZ-_1332ZN=?QIR=,TF"V(%I1 M1,A1P'NCT`%1)$:!Z(W"+D1A@00A!-)+7Q@^@(Q/47\0?T`0)I'LSZ[HC((1 MQC@P59PTE\_MP@G*D:Q2OO*^I#'^K%=*C\42/9G.1Q0<5]2%/;W,':G MF9W2S#HH"HE"6\*[>'^(\R-0>0448^D$ZU9,5Q)TBGV?H[!?.V2`>'R.4=@O M'M*M'HH"WU![=6Y.P:<"A75IJC]7T&XM7;8[[N$.P#FFTH.9?JDX+?-)DU4[L3J4:8\ M'4R>'8Q+'^%:FFLI::2OO#_4.QA-"??RZ M1H,+1(F;`S]QX.<<"+>C:J7/-]%YP]YMEC_H`37Y%399#K=IH?'A+Q7G<+-? MJS7,5:(>_M$U9:2:.\+-BKI9T1,K>LX*-V/^%2W](EGK%TB>;+7N*N3`C9Z0WZN$E%M5M7:VKO.Q5(]EG1!\B1;OI-5F$-#:+KP]^Z?LR>*$ MEV#\'\P[\V7MF]K8&AJ!?F)"&16^&U=TXW8KBW%MTOJ5U3UV!E21X=J,>'/3 MN&:F5X/\G1-JN%$P\8EH;(@SH&/*]',G.H4,T]J$K+P_S?S4<\&#;:Q'9Y(] MC*7WN-,C=0W9(8=/).:P.-T9 MI0%O;(W3:P\P_E3@2^:%=9N7<]=APG%1FYA5[3H`EF,M"^*E>N'2VX\KD23F MSI2J6G+[77VWLW='N_/*+NZT=9LB?,Z-T1=#Y#KJ@-\5E/0[53;`XE#L-Q;' M&:;;O71FG83DQ;"\R?K!9N^[S6QLE[H&]5)G'>S=SV:AS7!E+T9O;G1$97-C2A4:6UESLC!RW/DX!58 M'%HL,N0I6D!SD%"2(L_12H(\M.0(&T4L,F4-6K/(49+07VB5`;<6$?U9;,6B M/PN>17\VM(S^+'@._5GP4O3GP$LQZ<#+TD*YL`7TZ1BM0^\L6D=3.SOZ&&>> MJ'-]5K:^[B:M]SC_YP,C?]<=^[4R^KQ9^)-R&;P)DLEZZ?6X:U?37G?>--U@ M$)@7J`%!L*L/5H*3D$K().02^J+!J#X8"4(AH9!02"@D%!(*"86$PD)AH;!0 M6"@L%!8*"X6%PD)AH5BA6*%8H5BA6*%8H5BA6*%8H=B>\E6?J7Y8C_783SO] MJ:SGKP]';]_OO>G/:K2ZN;U(PC4/ZG[HJ%Y4M1]_*W&ZPVJ^:KT^:)OE?KG< MI*>K+DCT>%G6>KRZO)VVU;+;I$O?/AV8G.[B=Q^&SOTK2E#PTK>;J6$_!0^K M:]^L-BM@^%YSIP^J[WK4M#?E0I_IPWI6-YW'`#Y#6/V8?:YGOGULZ`.N14BO M)1TVBT7SP\]^&4;MHU#\2`_;\L;WQ9[M&7V+8##X?Y\>[A/NQV[X.PY7ZE@E MN%[Y_?7:.#57KE_8WZ4G6A.AI2VT]E[+$5P;H741VG0+;7*OS2+VED=HBPBM MB3+.1.S.;&,=;<0<0[8Q8A\S_6&5.?Z\TEOZ5+7]7!E+UA-3"],96YG=&@@-#,X,"]4>7!E+TUE=&%D871A/CYS=')E M86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T M82\B('@Z>&UP=&L](C,N,2TW,#$B/@H@("`\3Y396-U&-H86YG92!#;VUM:7-S:6]N/"]P9&9X.D-O;7!A;GD^"B`@("`@("`@ M(#QP9&9X.E-O=7)C94UO9&EF:65D/D0Z,C`P.#`Q,C@Q.3(S-3D\+W!D9G@Z M4V]U&%P.DUE=&%D M871A1&%T93XR,#`X+3`Q+3(X5#$T.C(W.C4Q+3`U.C`P/"]X87`Z365T861A M=&%$871E/@H@("`@("`\+W)D9CI$97-C&UL;G,Z>&%P M34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@("`@ M("`\>&%P34TZ1&]C=6UE;G1)1#YU=6ED.C!E8V8Y,6%D+3EA86,M-#1D,2TY M8V0X+6)E8SEF9#5B9&,P8SPO>&%P34TZ1&]C=6UE;G1)1#X*("`@("`@("`@ M/'AA<$U-.DEN&UL.FQA M;F<](G@M9&5F875L="(^,3DS-"!!0U0@15A!34E.051)3TX@4D503U)4("`@ M(#PO -----END PRIVACY-ENHANCED MESSAGE-----